The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Management of Overactive Bladder
Abstract
Symptoms of overactive bladder are common, are often distressing, and may have serious adverse consequences. Myriad factors — disorders of the lower urinary tract, neurologic conditions, behavioral factors, and a variety of commonly prescribed drugs — may cause this syndrome. This review considers the pathophysiology, diagnostic evaluation, and current treatment of overactive bladder syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., van Kerrebroeck, P., Victor, A., & Wein, A. (2002) · Neurourology and Urodynamics · doi:10.1002/nau.10052 · Cited by 8,296
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & The Measurement Committee of the American Urological Association (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36966-5 · Cited by 3,436
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O'leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & Measurement Committee of the American Urological Association (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.071 · Cited by 1,940
Milsom, I., Abrams, P., Cardozo, L., Roberts, R. G., Thüroff, J., & Wein, A. J. (2001) · BJU International · doi:10.1046/j.1464-410x.2001.02228.x · Cited by 1,752
SCHURCH, B., STÖHRER, M., KRAMER, G., SCHMID, D. M., GAUL, G., & HAURI, D. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67283-7 · Cited by 822
The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia
Lepor, H., Williford, W. O., Barry, M. J., Brawer, M. K., Dixon, C. M., Gormley, G., Haakenson, C., Machi, M., Narayan, P., & Padley, R. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350801 · Cited by 792
van Kerrebroeck, P., Abrams, P., Chaikin, D., Donovan, J., Fonda, D., Jackson, S., Jennum, P., Johnson, T., Lose, G., Mattiasson, A., et al. (2002) · Neurourology and Urodynamics · doi:10.1002/nau.10053 · Cited by 669
Burgio, K. L., Locher, J. L., Goode, P. S., Hardin, J. M., McDowell, B. J., Dombrowski, M., & Candib, D. (1998) · JAMA · doi:10.1001/jama.280.23.1995 · Cited by 635
Urinary Incontinence: Does it Increase Risk for Falls and Fractures?
Brown, J. S., Vittinghoff, E., Wyman, J. F., Stone, K. L., Nevitt, M. C., Ensrud, K. E., & Grady, D. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04744.x · Cited by 557
A myogenic basis for the overactive bladder
Brading, A. F. (1997) · Urology · doi:10.1016/s0090-4295(97)00591-8 · Cited by 530
Cited by
Muscarinic receptor antagonists for overactive bladder
Abrams, P., & Andersson, K. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07205.x · Cited by 405
Drug-Induced Urinary Retention: Incidence, Management and Prevention
Verhamme, K. M. C., Sturkenboom, M. C. J. M., Stricker, B. H. C., & Bosch, R. (2008) · Drug Safety · doi:10.2165/00002018-200831050-00002 · Cited by 264
Kay, G. G., & Ebinger, U. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01849.x · Cited by 141
Chiang, C.-H., Wu, M.-P., Ho, C.-H., Weng, S.-F., Huang, C.-C., Hsieh, W.-T., Hsu, Y.-W., & Chen, P.-J. (2015) · BioMed Research International · doi:10.1155/2015/187819 · Cited by 43
Al-Mousa, R. T., & Hashim, H. (2018) · Neuro-Urology · doi:10.1007/978-3-319-90997-4_14 · Cited by 1
Metadata
- Authors
- Ouslander, J. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-19
- Volume
- 350
- Issue
- 8
- Pages
- 786-799
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2025896506
- Cited by
- 411
- References
- 68
- FWCI
- 31.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Overactive Bladder. https://app.cochat.ai/papers/10.1056/nejmra032662
- The paper
- Ouslander, J. G. (2004). Management of Overactive Bladder. New England Journal of Medicine. https://doi.org/10.1056/nejmra032662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.